In MYCN-amplified NBs, N-Myc is stabilised by several mechanisms and has a leading role in regulating different downstream pathways and proteins, notably including the anaplastic lymphoma kinase (ALK). The gene discussed is MYCN; the disease is Nijmegen breakage syndrome.